InsidersTradesSigma
Explore the full record of transactions filed by Triola Anna Diaz, Directeur commercial. Officer active across 1 company, notably Entasis Therapeutics Holdings Inc.. Cumulatively, 2 disclosures have been recorded. Activity tracked since 18 January 2022. The latest transaction was disclosed on 18 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Anna Diaz Triola is the Chief Commercial Officer at Entasis Therapeutics Holdings Inc. She is responsible for commercial strategy and business development, aiming to maximize the company's growth and market impact. Her expertise in marketing and sales is crucial for achieving business objectives.